Navigation Links
MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS
Date:11/12/2010

Status of Phase II H5N1 clinical trial Enrollment is ongoing and vaccination has commenced in the Company's phase II clinical trial with its H5N1 pandemc influenza vaccine. Interim results from this study are expected within three months. Financial Results Consolidated loss for the three-month period ended September 30, 2010 was $4,104,000 or $0.03 per basic and diluted share compared to a loss of $3,165,000 or $0.03 per basic and diluted share for the three-month period ended September 30, 2009.  Since the beginning of the year the consolidated loss was $11,766,000 or $0.09 per basic and diluted share compared to a loss of $8,584,00 or $0.09 per basic and diluted share. Increase in the loss for the three and nine-month period is explained by the increase in R&D expenses in relation with the Phase II clinical trials that is underway.

Cash and cash equivalents were $14.7 million as at September 30, 2010.

As at November 12, 2010, there were 136,912,102 common shares issued and outstanding, 7,344,047 stock options outstanding, 3,796,982 unit options outstanding and 26,209,586 warrants outstanding.

Detailed financial statements and the MD&A are available at www.medicago.com or www.sedar.com. Grant of stock options Pursuant to terms and conditions of Medicago Inc.'s stock option plan, the company has granted 239,000 stock options to employees. The stock options were issued at an exercise price of 0.40 cents, will vest in three yearly instalments and are set to expire 10 years from the date of the grant. About Medicago Medicago is committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against pandemic and seasonal influenza using a transient expression system which produces recombinant vaccine antigens in non-tr
'/>"/>

SOURCE Medicago Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Medicago initiates work on Swine Flu strain
2. Medicago succesfully expresses VLP antigen for A H1N1 strain
3. Medicagos H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
4. Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
5. Medicago begins human clinical testing with its avian flu pandemic vaccine
6. Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy
7. Medicago to present at the U.S. Department of Health and Human Services Global Health Security Initiative Workshop
8. Medicago reports positive Phase I results for its avian flu pandemic vaccine
9. Medicago named in Presidential report on meeting the challenges of pandemic influenza
10. Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs and files two PCT patent applications
11. Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015 AACC International unveiled the ... the grain scientists’ Centennial Meeting and also issued ... marks the 100th anniversary of AACC International (AACCI), ... Minnesota, U.S.A. on October 18-21, 2015. The meeting ... are looking to the next 100 years of ...
(Date:3/6/2015)... LYNBROOK, N.Y. , March 6, 2015 ... biopharmaceutical company developing first in class collagenase-based products marketed ... in the U.S. and XIAPEX ®  in the EU, ... and live audio webcast at 8:30 a.m. ET on ... and full year 2014 financial results and provide a ...
(Date:3/6/2015)... Anton Paar has released an application flash regarding ... Sodium hydroxide (NaOH, also known as lye or ... products including pretzels, colored fabrics, soap and aluminum foil. ... industry; its applications range from the food and beverage ... NaOH is used in the production of downstream ...
(Date:3/5/2015)... 2015  DuPont (NYSE: DD ) announced ... Conference held today in New York ... discussed strategy, progress and plans to accelerate growth ... and growing the company,s leading position in high-value advanced ... priority for DuPont. Discussing the company,s Advanced ...
Breaking Biology Technology:AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4
... expectant parents offered by Family Cord Blood Services, a ... a basic course on cord blood banking., WHEN/ ... Avenue (near Bundy and Olympic) Los Angeles, CA 90025 ... (Breakfast will be served), Space ...
... MANILA, Philippines, Feb. 13 After a ... ground with another year,of double-digit growth and new ... report released today by the International Service for ... crop,area grew 12 percent or 30.3 million acres ...
... Lentigen Corporation today,announced the company is moving ... University of Maryland Baltimore County,TechCenter to a ... Located along Maryland,s I-270 technology corridor, the ... as a leading,developer and manufacturer of lentiviral ...
Cached Biology Technology:FREE Infant CPR Training and Cord Blood Banking 101 for Expectant Parents 2Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 2Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 3Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth 4Lentigen to Move Headquarters and Manufacturing to Gaithersburg 2
(Date:2/25/2015)... LITTLE ROCK, Ark. , Feb. 25, 2015 ... of software and billing in the Health and ... software as well as to MYiCLUBonline.  The latest ... MYiCLUBonline and the inclusion of cardless check-in via ... demonstrated for the first time through interactive displays ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... journal Science, researchers at the University of Texas Medical ... to a test that will enable medical science to estimate ... mad cow disease, which can take as long as 40 ... also help prevent accidental transmission of the malformed proteins that ...
... blackjack to investors picking stocks, humans make a ... versus reward. However, laboratory studies have not been ... information-processing "subcortical" regions of the brain function in ... and colleagues at the California Institute of Technology ...
... drinkers are familiar with the ring-shaped stains that result ... brown stain is not evenly distributed, but instead concentrated ... Wong, a professor of materials science and engineering, physics, ... has found the same "coffee-ring" formation in drying drops ...
Cached Biology News:Prion find points way to test for human 'mad cow' disease 2Brain's 'gambling circuitry' identified 2Brain's 'gambling circuitry' identified 3Ring-like formations in drying DNA drops could affect hybridization studies 2
... (Vesicle-Associated Membrane Protein 2, Synaptobrevin ... share homology with any other ... is expected that the antibody ... Macaca multata and bovine due ...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
Biology Products: